|
2025
|
Invention
|
Compositions and methods for increasing efficiency of cardiac metabolism.
Compositions and metho... |
|
|
Invention
|
Methods of treating kidney conditions using modified forms of trimetazidine.
The invention provi... |
|
|
Invention
|
Methods of treating non-obstructive hypertrophic cardiomyopathy using modified forms of trimetazi... |
|
2024
|
Invention
|
Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl] piperazin-1-yl]ethyl pyridine-3-car... |
|
|
Invention
|
Methods of treating heart failure with hibernating myocardium using modified forms of trimetazidi... |
|
|
Invention
|
Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate... |
|
|
Invention
|
Methods of treating heart failure with reduced ejection fraction using modified forms of trimetaz... |
|
2023
|
Invention
|
Methods of treating kidney conditions using modified forms of trimetazidine. The invention provid... |
|
|
Invention
|
Compositions and methods for increasing efficiency of cardiac metabolism. Compositions and method... |
|
|
Invention
|
Methods of treating heart failure with preserved ejection fraction using modified forms of trimet... |
|
|
Invention
|
Compounds and methods for increasing efficiency of cardiac metabolism. The invention provides com... |
|
2022
|
Invention
|
Crystal forms of 2-[4-[(2,3,4- trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylat... |
|
|
Invention
|
Methods for treating cardiovascular conditions and methods of increasing the efficiency of cardia... |
|
|
Invention
|
Combination therapies.
The invention provides combination therapies that include CV-8972 and CV-... |
|
|
Invention
|
Combination therapies. The invention provides combination therapies that include CV-8972 and CV-8... |
|
2021
|
Invention
|
Methods of treating heart conditions using modified forms of trimetazidine. The invention provide... |
|
|
Invention
|
Modified release formulations of modified forms of trimetazidine. The invention provides pharmace... |
|
|
Invention
|
Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin -1-yl]ethyl pyridine-3-carboxylat... |
|
|
Invention
|
Modified release formulations of modified forms of trimetazidine.
The invention provides pharmac... |
|
|
Invention
|
Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carb... |
|
|
Invention
|
Dosing methods for treatment of cardiovascular conditions.
The invention provides methods of tre... |
|
|
Invention
|
Dosing methods for treatment of cardiovascular conditions. The invention provides methods of trea... |
|
|
Invention
|
Process for producing tca cycle intermediate conjugates.
The invention provides a process for pr... |
|
|
Invention
|
H2o crystal forms of a tca cycle intermediate conjugate.
The invention provides polymorphs of a ... |
|
|
Invention
|
Process for producing tca cycle intermediate conjugates and polymorphs of a tca cycle intermediat... |
|
2020
|
Invention
|
Combination therapy.
The present disclosure provides certain combination therapy technologies th... |
|
|
Invention
|
Methods of altering cardiac remodeling using compounds that promote glucose oxidation.
The inven... |
|
|
Invention
|
Methods of treating fibrosis using compounds that promote glucose oxidation.
The invention provi... |
|
|
Invention
|
Combination therapies that include an agent that promotes glucose oxidation and an inhibitor of p... |
|
|
Invention
|
Methods of altering cardiac remodeling using compounds that promote glucose oxidation. The invent... |
|
|
Invention
|
Methods of treating fibrosis using compounds that promote glucose oxidation. The invention provid... |
|
|
Invention
|
Methods of treating cancer using trimetazidine-based compounds.
The invention provides compositi... |
|
|
Invention
|
Methods of treating cancer using trimetazidine-based compounds. The invention provides compositio... |
|
2019
|
Invention
|
Methods of treating rheumatic diseases using trimetazidine-based compounds. The invention provide... |
|
|
Invention
|
Tca cycle intermediates and methods of use thereof.
The invention generally relates to non-oral ... |
|
|
Invention
|
Compositions and methods for treating and preventing leber's hereditary optic neuropathy.
Compos... |
|
|
P/S
|
Pharmaceuticals for treatment of diseases or dysfunction of the mitochondrial disorders, genetic ... |
|
|
P/S
|
Pharmaceuticals for treatment of mitochondrial disorders, genetic diseases, cardiovascular diseas... |
|
2018
|
P/S
|
Pharmaceuticals for treatment of cardiovascular diseases |
|
|
P/S
|
Pharmaceuticals for treatment of mitochondrial disorders, genetic diseases, neurological diseases... |
|
|
P/S
|
Research and development for pharmaceuticals |
